Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial complex IV deficiency in which the cause of the disease is a mutation in the COA3 gene.
Features include always present findings: Epicanthus, Difficulty with thinking and memory (cognitive impairment), Short stature, and Nerve damage affecting sensation and movement (sensorimotor neuropathy) and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Difficulty with thinking and memory (cognitive impairment), Nerve damage affecting sensation and movement (sensorimotor neuropathy), Global developmental delay |
COA3 encodes cytochrome c oxidase assembly factor 3 (106 aa). Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. Highest expression in Kidney Medulla (196.4 TPM) and Kidney Cortex (125.2 TPM).
Mitochondrial complex IV deficiency, nuclear type 14 is associated with mutations in the COA3 gene on chromosome 17.
The COA3 protein participates in Metallochaperone inserts 2Cu2+ into MT-CO2 and Metallochaperone inserts Cu2+ into MT-CO1 pathways.
COA3 is classified as a druggable target with score 0.0.
Genetic testing for COA3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 10 always present features.
No clinical trials have been registered for mitochondrial complex IV deficiency, nuclear type 14.
1 publication has been identified in PubMed for mitochondrial complex IV deficiency, nuclear type 14. Research spans Review / Meta-Analysis (100%).
Antolínez-Fernández Á (2024). [PMID: 38855161](https://pubmed.ncbi.nlm.nih.gov/38855161/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Growth and development | 1 | Short stature |
Lab test results | 1 | Decreased activity of mitochondrial complex IV |
Muscles | 1 | Cytochrome C oxidase-negative muscle fibers |